Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,084.27%
#4 Black Phoenix Black Phoenix +336.48%
#5 aPriori aPriori +113.53%
#6 Bedrock Bedrock +74.54%
#7 Cysic Cysic +46.36%
#8 Prom Prom +40.86%
#9 Playnance Playnance +34.97%
#10 COTI COTI +30.93%
Coin of the day
Wrapped One Wrapped One
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Classement en actions #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Prix de l'action
$0.0009
Dernière synchronisation: 2025-05-27
Capitalisation boursière
$1.15K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Arch Therapeutics, Inc. (ARTH)

Catégorie

Healthcare
EPS pour Arch Therapeutics, Inc. (ARTH)
EPS au June 2024 TTM : $-2.86
Selon les derniers rapports financiers et le cours de l'action de Arch Therapeutics, Inc., l’EPS actuel de la société (TTM) est de $-2.86. À la fin de 2022, la société avait un EPS de $-3.56 une diminution par rapport à celui de 2021, qui était de $-5.97.
Historique de l'EPS de Arch Therapeutics, Inc. de 2011 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -705.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,069.93%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -579.02%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR